KR970706391A - 인터루킨-1 길항제(intracellular isoform of the interleukin-1 receptor antagonist) - Google Patents

인터루킨-1 길항제(intracellular isoform of the interleukin-1 receptor antagonist)

Info

Publication number
KR970706391A
KR970706391A KR1019970701931A KR19970701931A KR970706391A KR 970706391 A KR970706391 A KR 970706391A KR 1019970701931 A KR1019970701931 A KR 1019970701931A KR 19970701931 A KR19970701931 A KR 19970701931A KR 970706391 A KR970706391 A KR 970706391A
Authority
KR
South Korea
Prior art keywords
interleukin
antagonist
intruellular
isoform
receptor antagonist
Prior art date
Application number
KR1019970701931A
Other languages
English (en)
Other versions
KR100237936B1 (ko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR970706391A publication Critical patent/KR970706391A/ko
Application granted granted Critical
Publication of KR100237936B1 publication Critical patent/KR100237936B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
KR1019970701931A 1994-10-13 1995-10-12 인터루킨-1 길항제 KR100237936B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI94A002097 1994-10-13
ITMI942097A IT1270662B (it) 1994-10-13 1994-10-13 Antagonista della interleuchina-1
PCT/EP1995/004023 WO1996012022A1 (en) 1994-10-13 1995-10-12 Intracellular isoform of the interleukin-1 receptor antagonist

Publications (2)

Publication Number Publication Date
KR970706391A true KR970706391A (ko) 1997-11-03
KR100237936B1 KR100237936B1 (ko) 2000-01-15

Family

ID=11369705

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019970701931A KR100237936B1 (ko) 1994-10-13 1995-10-12 인터루킨-1 길항제

Country Status (19)

Country Link
US (1) US5739282A (ko)
EP (1) EP0786002B1 (ko)
JP (1) JPH10509306A (ko)
KR (1) KR100237936B1 (ko)
CN (2) CN1224707C (ko)
AT (1) ATE303439T1 (ko)
BR (1) BR9509317A (ko)
CA (1) CA2202470C (ko)
DE (1) DE69534419T2 (ko)
EE (1) EE03697B1 (ko)
ES (1) ES2243942T3 (ko)
HK (2) HK1002659A1 (ko)
IT (1) IT1270662B (ko)
MX (1) MX9702616A (ko)
NO (1) NO320494B1 (ko)
PT (1) PT786002E (ko)
RU (1) RU2193064C2 (ko)
UA (1) UA65522C2 (ko)
WO (1) WO1996012022A1 (ko)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075222A (en) * 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
US5872095A (en) * 1990-05-01 1999-02-16 Chiron Corporation IL-1 receptor antagonists medicaments
IL129669A0 (en) 1996-10-31 2000-02-29 Applied Research Systems Ice inhibiting peptides
JP4771563B2 (ja) * 1996-12-06 2011-09-14 アムジエン・インコーポレーテツド Ｉｌ−１媒介疾患を処置するためにｉｌ−１インヒビターを使用する組合せ療法
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
IL126562A0 (en) * 1998-10-14 1999-08-17 Interpharm Lab Ltd Expression and secretion of icil-1 receptor antagonist type ii
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders
US7166712B2 (en) * 2000-07-12 2007-01-23 Philadelphia, Health And Education Corporation Mammalian MDM2 binding proteins and uses thereof
EP1703893B1 (en) * 2003-12-23 2012-04-11 Genentech, Inc. Novel anti-il 13 antibodies and uses thereof
AU2005269995C1 (en) 2004-07-06 2011-12-01 Zymogenetics, Inc. Pharmaceutical composition comprising FGF18 and IL-1 antagonist and method of use
CN101918018B (zh) 2007-11-14 2012-12-05 再生医药有限公司 使用白介素-1受体拮抗剂作为骨髓保护剂的方法
CN101690801B (zh) 2009-10-26 2012-08-01 上海交通大学 白细胞介素-1受体拮抗剂的用途及其药物组合物
US9359405B2 (en) 2011-03-14 2016-06-07 Phlogo Aps Antagonists of the interleukin-1 receptor
JP6234446B2 (ja) 2012-06-08 2017-11-22 アルカーメス，インコーポレイテッド ムチンドメインポリペプチドに連結された活性タンパク質を含む融合ポリペプチド
US20160000936A1 (en) 2014-06-10 2016-01-07 Abbvie Inc. Biomarkers for inflammatory disease and methods of using same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148009B1 (ko) * 1988-05-27 1998-08-01 그래고리 비. 아보트 인터루킨-1 억제제
HUT64582A (en) * 1989-11-29 1994-01-28 Synergen Inc Method for producing recombinant human interleukin-1 inhibitor
AU649245B2 (en) * 1990-04-02 1994-05-19 Amgen, Inc. Methods for treating interleukin-1 mediated diseases
AU7683391A (en) * 1990-04-27 1991-11-27 Upjohn Company, The Modified interleukin-1 inhibitors
ATE178094T1 (de) * 1990-05-01 1999-04-15 Chiron Corp Interleukin-i antagonist und seine verwendung

Also Published As

Publication number Publication date
EE9700090A (et) 1997-10-15
NO971624L (no) 1997-05-30
NO320494B1 (no) 2005-12-12
EP0786002B1 (en) 2005-08-31
CA2202470A1 (en) 1996-04-25
HK1002659A1 (en) 1998-09-11
BR9509317A (pt) 1997-10-14
CN100363053C (zh) 2008-01-23
CA2202470C (en) 2008-09-16
EE03697B1 (et) 2002-04-15
IT1270662B (it) 1997-05-07
CN1224707C (zh) 2005-10-26
CN1679919A (zh) 2005-10-12
JPH10509306A (ja) 1998-09-14
ITMI942097A0 (it) 1994-10-13
MX9702616A (es) 1998-04-30
WO1996012022A1 (en) 1996-04-25
EP0786002A1 (en) 1997-07-30
ES2243942T3 (es) 2005-12-01
AU701471B2 (en) 1999-01-28
US5739282A (en) 1998-04-14
AU3841795A (en) 1996-05-06
DE69534419T2 (de) 2006-06-14
DE69534419D1 (de) 2005-10-06
UA65522C2 (en) 2004-04-15
NO971624D0 (no) 1997-04-09
RU2193064C2 (ru) 2002-11-20
HK1081124A1 (en) 2006-05-12
CN1161058A (zh) 1997-10-01
ATE303439T1 (de) 2005-09-15
ITMI942097A1 (it) 1996-04-13
KR100237936B1 (ko) 2000-01-15
PT786002E (pt) 2005-11-30

Similar Documents

Publication Publication Date Title
HK1081124A1 (en) Intracellular isoform of the interleukin-1 receptor antagonist
PT735818E (pt) Proteinas inflamatorias de macrofagos pim-3 pim-4 e pim-1y
NO960630D0 (no) Heterocykler anvendelige som neurokinin antagonister
NO900227L (no) Ekstruderbar elastisk gel for anvendelse som baerer for terapeutisk middel.
DK0669979T3 (da) C-C CKR-1, kemokinreceptor
DK0793714T3 (da) Anvendelse af stamcellefaktor og opløselig interleukin-6-receptor til ex vivo ekspansion af hæmatopoietiske multipotentielle celler
DK0751992T3 (da) Karendotelvækstfaktor 2
TR199900318T2 (xx) IL-8 resept�r antagonistleri.
DE69432951D1 (de) Regulierung der fruchtbarkeit mit transformierendem wachstumfaktor beta
TR199700956T1 (xx) Indazolkarboksamidler.
TR200103448T2 (tr) IL-8 reseptör antagonistleri.
ATE57526T1 (de) P-acylaminobenzamide.
IT1294932B1 (it) Uso di 2-amminotetraline-6,7 sostituite per la preparazione di composizioni farmaceutiche atte al trattamento di patologie
IT8784946A0 (it) Agenta espansivo particolarmente indicato per cementi portland eprocedimento per la sua preparazione.
IT8430790V0 (it) Dispositivo orientabile per i comandi di movimento delle poltrone particolarmente per dentisti.
IT8723123A0 (it) Metodo per la protezione superficiale di frese diamantate per uso odontoiatrico, e attrezzatura per la sua applicazione.
IT8920060A0 (it) Impianto per la riduzione di pressione del gas metano tra le centrali di pompaggio e le reti di distribuzione all'utenza.
ITCT920022A0 (it) Test immunoenzimatico competitivo per il rilievo quantitativo del frammento secretorio presente nel siero, nella saliva, nell'urina, nelle lacrime, nel succo gastrico, nel secreto vaginale, nelle feci.
KR970017323U (ko) 에스, 알, 에스 자기 진단장치의 방전구조
IT8704778V0 (it) Apparecchiatura ad ingombro ridotto per il supporto di strumenti operativi pendenti,in particolare per strumenti odontoiatrici
KR900020697U (ko) 초음파 가습기의 진동자용 고무링
RU98114769A (ru) Способ повышения вестибулярной устойчивости человека

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20081010

Year of fee payment: 10

LAPS Lapse due to unpaid annual fee